Compare BLTE & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | SPT |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 327.6M |
| IPO Year | 2021 | 2019 |
| Metric | BLTE | SPT |
|---|---|---|
| Price | $152.68 | $6.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $198.00 | $11.75 |
| AVG Volume (30 Days) | 102.1K | ★ 1.3M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.11 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $457,547,000.00 |
| Revenue This Year | N/A | $8.86 |
| Revenue Next Year | $492.11 | $8.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.72 |
| 52 Week Low | $56.68 | $4.92 |
| 52 Week High | $200.00 | $24.74 |
| Indicator | BLTE | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.18 | 61.28 |
| Support Level | $148.06 | $6.52 |
| Resistance Level | $161.28 | $7.39 |
| Average True Range (ATR) | 5.58 | 0.36 |
| MACD | -0.80 | 0.12 |
| Stochastic Oscillator | 15.51 | 95.51 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.